-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
-
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes New data and real-world findings further emphasize pediatric safety, glycemic control and treatment satisfaction Exploratory analysis of inhaled insulin used with AID systems provides insight on the…
-
Quantinuum Announces Closing of Upsized Initial Public Offering
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the…
-
Zuellig Pharma Unveils State-of-the-art Clinical Trial Support Innovation Center in South Korea to Support both Domestic and Global Clinical Research Needs
Gyeonggi-Do, South Korea Zuellig Pharma, a leading healthcare solutions company in Asia, today announced the grand opening of its new state-of-the-art Clinical Trial Support (CTS) Innovation Center in South Korea. The opening of this facility underscores Zuellig Pharma’s continued investment and commitment to advancing healthcare, reinforcing its position as a trusted regional partner in driving…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
-
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, attended the 2026 Tencent Cloud AI Industry Applications Summit in Beijing, where it showcased its “AI + Chronic Disease Services” digital solution developed in collaboration with Tencent Health. The conference, themed “Agent…
-
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels June 05, 2026 02:00 ET | Source: Chiesi Global Rare Diseases PARMA, Italy, June 05, 2026 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a…
-
Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics
New Frost & Sullivan White Paper Highlights Emerging Opportunities Across Healthy Aging, Functional Nutrition, Personal Care, and Preventive Healthcare SHANGHAI, June 4, 2026 /PRNewswire/ — Frost & Sullivan’s latest white paper, Global Ergothioneine Industry Current Landscape and Development Trends, reveals that ergothioneine (EGT) is rapidly transitioning from a niche antioxidant ingredient into a scalable, science-backed platform for…
-
Havih, a Maxwell Biosciences Subsidiary, Announces Partnership with the Government of Andhra Pradesh
This partnership will establish a new research and production facility in Andhra Pradesh, driving India’s transition toward pharmaceutical leadership and creating high-tech jobs Pulivendula, Andhra Pradesh, India Havih Envirosciences, an Indian citizen-owned and operated life sciences company and subsidiary of Maxwell Biosciences, announced a strategic partnership with the Government of Andhra Pradesh to establish advanced…
-
Anderson Diagnostics and MAHE Launch Groundbreaking Centre of Excellence in Reproductive Genomics
MAHE-Anderson COE to Revolutionise Women’s Healthcare Diagnostics Manipal, Karnataka, India; Chennai, Tamil Nadu, India Anderson Diagnostics & Labs, Chennai, in a landmark partnership with Manipal Academy of Higher Education (MAHE), today announced the formal launch of the MAHE-Anderson Centre of Excellence (COE) in Reproductive Genomics. Inaugural Ceremony of Centre of Excellence in Reproductive Genomics…
-
Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches 2026 global employee stock purchase plan Paris, June 4, 2026. Sanofi’s global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s…
-
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 4, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06,…
-
Gujarat becomes the New Hub in Organ Transplantation
Zydus Hospitals Ahmedabad and Vadodara reach new heights in advanced transplant care AHMEDABAD, India, June 4, 2026 /PRNewswire/ — Organ transplantation in India has come a long way over the past five decades, and Gujarat has been significantly contributing to this milestone, with Zydus Hospitals at its forefront. Across its centres in Ahmedabad and Vadodara, Zydus Hospitals has…
-
World Regional Anaesthesia and Pain Medicine day Workshop brings the Spotlight on Strengthening Patient Safety Standards
New Delhi, Delhi, India BD (Becton, Dickinson and Company) recently participated as Knowledge Partner at the World Regional Anaesthesia & Pain Medicine (RAPM) Day Workshop. With the objective of reinforcing patient-safety practices in Regional Anaesthesia, BD India/South Asia focused on enabling real-time, hands-on learning for clinicians to advanced spinal anaesthesia solutions and supporting faculty-led live…
-
Kapiva Launches Rs. 50 Crore Innovation Fund to Build Evidence-Based, Future-Ready Ayurveda Ecosystem
Bengaluru, Karnataka, India Kapiva, India’s first modern holistic Ayurvedic brand for millennials, today announced the launch of the Kapiva Innovation Fund (“KIF”), a commitment of up to Rs. 50 crore to support research and innovation in Ayurveda. KIF will back projects across academia, labs and startups that focus on R&D in Ayurvedic science and create…
-
It’s Not a Prenatal Class, It’s a Social Club With a Curriculum for Parenthood — Launching in Miami This August
MIAMI, June 03, 2026 (GLOBE NEWSWIRE) — Miami has attracted transplants, globally mobile families, and ambitious young professionals who are building lives far from the support systems they grew up with. At the same time, lifelong Miami families are navigating parenthood in a city that can often feel fast-paced, disconnected, and isolating during one of…
-
Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor
Pioneering Physician and Interventional Pulmonology Innovator Joins Noah Medical to Accelerate the Next Era of Robotic-Assisted Lung Cancer Diagnosis and Treatment June 03, 2026 08:00 ET | Source: Noah Medical SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) — Noah Medical, a medical robotics company dedicated to earlier, more accurate lung cancer diagnosis, announced the…
-
HBSUK and Hexaware partner to enhance clinician onboarding efficiency
MUMBAI, India, ISELIN, N.J. and LONDON, June 3, 2026 /PRNewswire/ — HBSUK, a UK-based healthcare services provider, and Hexaware Technologies (NSE: HEXT), a global IT services and solutions provider, have announced a strategic collaboration to enhance HBSUK’s workforce management proposition. With around 7.22 million people currently awaiting treatment within the NHS, healthcare providers face growing…
-
Morepen Bags Rs. 825 Crore Global Deal
Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major. Morepen Bags Rs. 825 Crore Global Deal, Expands into High-Growth CDMO Segment Supplies under the mandate are expected to commence within the…
-
Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21% Adj EBITDA Growth
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26. Q3 FY 26 saw strong performance across its key business segments. CDMO saw a revenue growth of over 16% spurred on by double digit increase in volumes. The…
-
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. June 02, 2026 10:05 ET | Source: Jersey College TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) — Jersey College, the institution dedicated to excellence in nursing education, provides an Associate Degree in Nursing program at its Teterboro and Ewing, N.J., campuses, offering…
-
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four decades of MAPS advocacy by turning the lens of psychedelic research toward people directly harmed by the war on drugs MAPS…
-
Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters
The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally CARLSBAD, Calif., June 2, 2026 /PRNewswire/ — As laboratories increasingly seek faster, more cost-efficient alternatives to legacy single-analyte testing, demand for scalable multi-analyte proteomic workflows is…
-
Raay Neo Pharma Launches to Transform India's Healthcare Landscape with Quality-Driven, Patient-Centric Pharmaceutical Solutions
Mumbai, Maharashtra, India Raay Neo Pharma, a next-generation pharmaceutical company, has officially unveiled its operations with the aim to contribute to quality healthcare for all Indians. Founded using a flexible and scalable operational framework and supported by more than five decades of diverse entrepreneurial success, Raay Neo Pharma will be introducing its range of more…
-
Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time
Company sets a benchmark again in pharmaceutical excellence reinforcing its global leadership in quality and regulatory compliance Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, with Zero adverse observations (No Form 483 issued…
-
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development June 01, 2026 11:50 ET | Source: J-Star Holding Co., Ltd TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today provided additional details regarding the commitment…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
Acquisition supports Servier’s strategic ambition in rare neurology for patients with high unmet medical needs. Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. Transaction represents total value of up to $2.65 billion. SURESNES, France, June 1, 2026 /PRNewswire/ — Servier, an independent international pharmaceutical group governed by a foundation, today announced that…
-
Platinum Industries Announces Entry into Life Sciences; Collaborates with Dr. Abhigyan Upadhyay to Lead the New Enterprise, Rivadu Lifesciences Pvt. Ltd.
Strengthens leadership to build a research-driven and globally scalable model in high-value life sciences segments Mumbai, Maharashtra, India Platinum Industries Ltd. [NSE: PLATIND; BSE: 544134], an innovation-driven specialty chemicals company announced its strategic entry into the life sciences sector, marking a significant step in its next phase of growth. As part of this expansion, the…
-
Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Dividend
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), announced its financial results for the fourth quarter and the full year ended March 31, 2026. The company delivered a steady performance during Q4 FY26, with healthy revenue growth and improved operating profitability driven by its core domestic…
-
Johnson & Johnson’s Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, versus hormone therapy alone, potentially shifting a decades-long treatment paradigm
Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the risk of developing metastasis or death1 Data selected to open the plenary presentation at ASCO 2026 and published in The New England Journal…
-
Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
REDWOOD CITY, Calif., May 31, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced detailed results from the global, randomized Phase 3 RASolute 302 clinical trial evaluating daraxonrasib, an oral RAS(ON) multi-selective inhibitor, in patients with previously treated metastatic pancreatic…
-
Niche Group Advances India's Vision Across Organic Farming and Cancer Treatment
At the same time, he revealed that Niche Agriculture and Pharmaceuticals Limited (NAPL) is working on affordable medicines for diseases such as cancer, epilepsy, and Alzheimer’s. Hundreds of PhD scholars were also interviewed and selected for opportunities during the event. Nestled amidst the beauty of nature, the auditorium of CSKHPKV transformed into far more than…
-
Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26
Gurugram, Haryana, India Morepen Laboratories Limited reported strong Q4 FY26 performance with net profit rising 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. Revenue growth during the quarter was supported by export momentum and expansion in the Medical Devices business, while operational momentum strengthened toward the latter…
-
Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma in advanced NSCLC Plasma MET test showed high concordance with tissue IHC/FISH in EGFR-mutated NSCLC following progression on first-line targeted therapy (AUC=0.97) Baseline and longitudinal profiling in METex14 skipping NSCLC identified biology associated with therapeutic…
-
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR…
-
World MS Day: National Policy Dialogue Adopts Landmark 10-Point Declaration Calling for Stronger Recognition of Invisible Disabilities in India
~Stakeholders urge reforms across disability certification, healthcare access, insurance, workplace inclusion and national health systems to improve outcomes for people living with Multiple Sclerosis and other invisible neurological conditions~ NEW DELHI, May 30, 2026 /PRNewswire/ — In a significant step towards strengthening disability-inclusive healthcare and social protection in India, Members of Parliament, policymakers, neurologists, disability…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.